YAP1 and gastric cancer: Although loss of function of NF2 and/or gene amplifications in YAP1/TAZ have not been identified in gastric cancer, YAP1 expression is progressively elevated with advancing cancer stage when compared with expression patterns in normal gastric tissue (3).